Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02049541
Title Study of BKM120; Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kami Maddocks

mantle cell lymphoma

follicular lymphoma

marginal zone B-cell lymphoma

lymphoplasmacytic lymphoma


Buparlisib + Rituximab

Age Groups: adult
Covered Countries USA

No variant requirements are available.